| [1] |
常琦，任明山，吴元波. 抗癫痫药物的致畸作用[J]. 中国神经免疫学和神经病学杂志，2016, 23(1): 55-58.
|
| [2] |
Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis[J]. Lancet, 2015, 386(10006): 1845-1852.
|
| [3] |
Vélez-Ruiz NJ, Pennell PB. Issues for Women with Epilepsy[J]. Neurol Clin, 2016, 34(2): 411-425.
|
| [4] |
MacDonald SC, Bateman BT, McElrath TF, et al. Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States[J]. JAMA Neurol, 2015, 72(9):981.
|
| [5] |
Richmond JR, Krishnamoorthy P, Andermann E, et al. Epilepsy and pregnancy: an obstetric perspective[J]. Am J Obstet Gynecol, 2004, 190(2):371.
|
| [6] |
Ottman R, Annegers JF, Hauser WA, et al. Higher risk of seizures in offspring of mothers than of fathers with epilepsy[J]. Am J Hum Genet, 1988, 43(3):257.
|
| [7] |
Battino D, Tomson T, Bonizzoni E, et al. Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry[J]. Epilepsia, 2013, 54(9): 1621-1627.
|
| [8] |
Vajda FJ, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy[J]. Epilepsia, 2008, 49(1): 172-175.
|
| [9] |
Pennell PB. Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest[J]. Epilepsia, 2008, 49 Suppl 9: 43-55.
|
| [10] |
Patel SI, Pennell PB. Management of epilepsy during pregnancy: an update[J]. Ther Adv Neurol Disord, 2016, 9(2): 118-129.
|
| [11] |
Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register[J]. J Neurol Neurosurg Psychiatry, 2006, 77(2): 193-198.
|
| [12] |
Campbell E, Kennedy F, Russell A, et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and ireland epilepsy and pregnancy registers[J]. J Neurol Neurosurg Psychiatry, 2014, 85(9):1029-1034.
|
| [13] |
Jentink J, Dolk H, Loane MA, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study[J]. BMJ, 2010, 341: c6581.
|
| [14] |
Vajda F, Graham J, Roten A, Lander CM, O’Brien, Eadie M. Teratogenicity of the newer antiepileptic drugs–the Australian experience[J]. J Clin Neurosci, 2012, 19(1): 57-59.
|
| [15] |
Harden CL, Meador KJ, Pennell PB, et al. Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society[J]. Neurology, 2009, 73(2): 133-141.
|
| [16] |
Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy[J]. Neurology, 2012, 78(21): 1692-1699.
|
| [17] |
Mawhinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy Results from the UK and Ireland epilepsy and pregnancy registers[J]. Neurology, 2013, 80(4): 400-405.
|
| [18] |
Pennell PB, Klein AM, Browning N, et al. Differential effects of antiepileptic drugs on neonatal outcomes[J]. Epilepsy Behav, 2012, 24(4): 449-456.
|
| [19] |
Hernández-Díaz S, Mittendorf R, Smith CR, et al. Association between topiramate and zonisamide use during pregnancy and low birth weight[J]. Obstet Gynecol, 2014, 123(1):21-28
|
| [20] |
Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study[J]. The Lancet Neurology, 2013, 12(3): 244-252.
|
| [21] |
Meador KJ, Baker GA, Browning N, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years[J]. JAMA Pediatr, 2014, 168(8):729-736.
|
| [22] |
Fairgrieve S, Jackson M J, Jonas P, et al. Population based, prospective study of the care of women with epilepsy in pregnancy[J]. BMJ, 2000, 321(7262):674-675.
|
| [23] |
Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry[J]. Lancet Neurology, 2011, 10(7): 609-617.
|
| [24] |
Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy[J]. Neurology, 2003, 60(4):575-579.
|
| [25] |
Vajda FJ, Obrien TJ, Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy[J]. J Clin Neurosci, 2004, 11(8): 854-858.
|
| [26] |
Vajda F J, Brien T J, Hitchcock A, et al. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months[J]. J Clin Neurosci, 2003, 10(5):543-539.
|